Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin
Department of Emergency Medicine
Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; North America; Pneumonia; Prospective Studies; Sputum; Streptococcus pneumoniae
Bacteria | Bacterial Infections and Mycoses | Chemical Actions and Uses | Emergency Medicine | Fluids and Secretions | Microbiology | Organic Chemicals | Pharmaceutical Preparations | Public Health | Respiratory Tract Diseases | Therapeutics
BACKGROUND: Limited information on antibiotic resistance of Streptococcus pneumoniae (SP) exists for patients discharged from emergency departments with community-acquired pneumonia.
OBJECTIVES: Using a standardized collection process, this study examined sputum microbiology in outpatient community-acquired pneumonia.
METHODS: This was a multicenter, prospective cohort study conducted in North American emergency departments between December 2001 and May 2003. Thirty-one emergency departments enrolled patients older than 18 years with a Pneumonia Severity Index of I to III. All patients received oral clarithromycin and were followed up for four weeks. SP resistance to macrolides and penicillin was determined by a central laboratory.
RESULTS: Among the 317 cultured sputum samples, 116 (37%; 95% confidence interval [CI] = 32% to 42%) grew an identifiable organism; 74 (23% of cultured cases; 95% CI = 19% to 28%) grew non-SP organisms and 42 grew SP organisms (SP positive; 13% of cultured cases; 95% CI = 10% to 17%). A total of 13 resistant organisms (4% of cultured cases; 95% CI = 2% to 6%) were identified. Resistance to macrolides occurred in nine patients (3% of cultured cases [95% CI = 1% to 5%]; 24% of SP-positive cases [95% CI = 11% to 37%]); and resistance to penicillin occurred in nine patients (3% of all sputum-positive cases [95% CI = 1% to 5%]; 21% of SP-positive cases [95% CI = 9% to 34%]). The four-week cure rates were similar in both groups.
CONCLUSIONS: Among outpatients with community-acquired pneumonia, half produced adequate sputum samples and most were culture negative. SP resistance was similar to rates from large national databases, and results were of little (if any) consequence. In low-risk Pneumonia Severity Index cases, sputum cultures should not be collected routinely.
bacterial pneumonia, sputum, microbiological sensitivity tests, pneumonia severity index (PSI), macrolide
DOI of Published Version
Acad Emerg Med. 2007 Jul;14(7):607-15. Epub 2007 May 3. Link to article on publisher's site
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Rowe BH, Campbell SG, Boudreaux ED, Colman I, Abu-Laban RB, Sivilotti ML, Clark S, Camargo CA. (2007). Community-acquired pneumonia in North American emergency departments: drug resistance and treatment success with clarithromycin. Emergency Medicine Publications and Presentations. https://doi.org/10.1197/j.aem.2007.02.026. Retrieved from https://escholarship.umassmed.edu/emed_pp/20